AIDS

In the quest to enhance our understanding of paediatric HIV and improve treatment outcomes, the EPIICAL project has worked tirelessly for the past eight years to gather and generate knowledge on HIV in children. Established with the ambitious goal of creating models to predict how children’s bodies respond to early antiretroviral therapy (ART) and treatment interruption,

EPIICAL is proud to have presented four abstracts at the CROI conference this year, sharing updated information on viral decay and the immune response of children living with HIV who begin treatment early in life.

The 23^rd International AIDS Conference take virtually place from today to July 10^th. Attendants have the possibility to engage with the latest HIV science, advocacy and knowledge and also to hear about recent data on COVID-19 and HIV during the Virtual COVID-19 Conference that will be held on July 10^th-11^th.

Just published – data on T & B cell memory and T cell function in early-treated children in the Journal of Immunology and AIDS.

Today we celebrate Human Rights Day. Percentage of HIV-infected children receiving antiretroviral therapy is still very low in low and-middle income countries, as reported by UNICEF.

“The mission is remission. We believe that an HIV remission/cure is attainable.”

Today we celebrate World AIDS Day: this year theme is “Communities make the difference”.